Canadian Cancer Trials Group Bulletins

Trial Management Group

Trial Closed to Accrual

Canadian Cancer Trials Group ES.2 (TROG 03.01) -- A Randomized Phase III Study in Advanced Oesophageal Cancer to Compare Quality of Life and Palliation of Dysphagia in Patients Treated with Radiotherapy Versus Chemo-Radiotherapy -- was closed to accrual on March 21, 2012.

Canadian Cancer Trials Group centres contributed 89 patients over the past 8 years (40%) which represents a significant contribution for an intergroup trial. The final Canadian patient was randomized on December 30, 2011 and therefore, all patients have completed protocol-mandated treatment at this time.

Thanks to all participating centres, staff and patients for making such a significant contribution to this trial.